Skip to main content

Table 1 Patient characteristics in REF, ABROAD and ICU

From: Prevalence of multidrug-resistant organisms in refugee patients, medical tourists and domestic patients admitted to a German university hospital

 

REF

ABROAD

ICU

number of patients

117

84

495

mean age; standard deviation (years)

19; 14.7

54; 24.0

66; 14.4

male (n; %; 95%CI)

85; 72.7; 63.6-80.5

59; 70.2; 59.3-79.7

341; 68.9; 64.6-72.9

COO a / admitted from (n; %)

Afghanistan

30; 25.6

1; 1.2

residents without

refugee history or

pre-treatment abroad

Syria

29; 24.8

-

Somalia

8; 6.8

3; 3.6

Algeria

7; 5.9

1; 1.2

Iraq

5; 4.3

1; 1.2

Pakistan

5; 4.3

-

Eritrea

5; 4.3

2; 2.4

Ethiopia

3; 2.6

3; 3.6

Turkey

-

11; 13.1

Greek

-

4; 4.8

Italy

-

4; 4.8

Morocco

-

4; 4.8

Nigeria

-

4; 4.8

India

-

3; 3.6

Iran

-

3; 3.6

Kuwait

-

3; 3.6

Croatia

-

2; 2.4

Ghana

-

2; 2.4

Hungary

-

2; 2.4

Saudi-Arabia

-

2; 2.4

Spain

-

2; 2.4

Sri Lanka

-

2; 2.4

Thailand

-

2; 2.4

Egypt

2; 1.7

4; 4.8

Other

8; 6.8 b

19; 22.6 c

Unknown

15; 12.8

-

department patients admitted to (n; %; 95%CI)

intensive care unit

-

-

495; 100

Surgery

13; 11.1; 0.6-18.3

12; 14.3; 7.6-23.6

495; 100; 99.3-100

general / vascular

6; 5.1 1.9-10.8

4; 4.7; 1.3-11.7

153; 30.9; 26.8-35.2

thoracic

-

2; 2.3; 0.2-8.3

273; 55.2; 50.7-59.6

traumatology

7; 5.9; 2.4-11.9

6; 7.1; 2.7-14.9

69; 13.9; 11.0-17.3

Internal medicine

20; 17.1; 10.8-25.2

39; 46.4; 35.5-57.6

 

Infectious diseases

10; 8.5; 4.1-15.2

9; 10.7; 5.0-19.4

-

Gastroenterology

3; 2.6; 0.5-7.3

9; 10.7; 5.0-19.4

Pneumology

2; 1.7; 0.2-6.0

5; 5.9; 1.9-13.3

Hematology / Oncology

-

9; 10.7; 5.0-19.4

Cardiology

3; 2.6; 0.5-7.3

7; 8.3; 3.4-16.4

Angiology

1; 0.9; 0.0-4.7

-

Rheumatology

1; 0.9; 0.0-4.7

-

Gynecology / Obstetrics

10; 8.5; 4.1-15.2

3; 3.6; 0.7-10.1

-

Urology

6; 5.1; 1.9-10.8

1; 1.2; 0.0-6.5

Pediatrics

44; 37.6; 28.8-47.0

8; 9.5; 4.2-17.9

Neurology

4; 3.4; 0.9-8.5

13; 15.5; 8.5-25.0

Psychiatrics

7; 5.9; 2.4-11.9

1; 1.2; 0.0-6.5

otherd

12; 10.3; 5.4-17.2

7; 8.3; 3.4-16.4

  1. (a) COO = country of origin; (b) = Albania, Iran, Jordan, Kosovo, Libya, Sudan, Tunisia, and Uganda with n = 1 each; (c) = Azerbaijan, Bangladesh, Bosnia, Bulgaria, Canada, China, Cuba, Cameroon, Denmark, Dominican Republic, Kazakhstan, Mozambique, Poland, Sudan, Taiwan, Togo, UK, USA, and Uzbekistan with n = 1 each; (d) = Ear-Nose-Throat (ENT), ophthalmology, orthopedics, and dermatology